Podrobno

Smoking and diabetes attenuate number of CD34$^{+}$ haematopoietic stem cells in peripheral blood of patients with advanced peripheral artery disease
ID Šernek, Barbara (Avtor), ID Kamnikar, Rok (Avtor), ID Šebeštjen, Miran (Avtor), ID Boc, Anja (Avtor), ID Boc, Vinko (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (788,94 KB)
MD5: 09D2E6375368F4BE6E867BDBA0BCBBEC
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1422-0067/24/20/15346 Povezava se odpre v novem oknu

Izvleček
Peripheral artery disease (PAD) is a globally prevalent problem with limited treatment options, leaving up to a fifth of patients remediless. The emergence of new studies on cell therapy in recent years offers a new promising option for their treatment. Our aim was to explore how the number of CD34$^{+}$ hematopoietic cells in the peripheral blood of PAD patients is associated with patients’ functional as well as atherogenic factors. We selected 30 patients with advanced PAD, recorded their performance in a walking test in standard conditions and sampled their blood for further analysis with an emphasis on CD34$^{+}$ cell selection and counting. No correlation of the CD34$^{+}$ cell number was confirmed with any of the observed laboratory parameters. There was an association between the claudication distance and the number of CD34$^{+}$ cells (r = −0.403, p = 0.046). The number of CD34$^{+}$ cells differed between patients with and without type II diabetes (p = 0.071) and between active smokers, past smokers, and non-smokers (p = 0.035; p = 0.068, p = 0.051, respectively), with both smoking and presence of diabetes type II having a negative effect on the number of CD34$^{+}$ cells. Our study demonstrated a dependence of the CD34$^{+}$ cell number on the patient’s characteristics.

Jezik:Angleški jezik
Ključne besede:CD34$^{+}$ cells, peripheral artery disease, smoking, diabetes type II, intermittent claudication
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2023
Št. strani:10 str.
Številčenje:Vol. 24, iss. 20, art. 15346
PID:20.500.12556/RUL-187756 Povezava se odpre v novem oknu
UDK:616.1
ISSN pri članku:1422-0067
DOI:10.3390/ijms242015346 Povezava se odpre v novem oknu
COBISS.SI-ID:177470723 Povezava se odpre v novem oknu
Datum objave v RUL:15.09.2026
Število ogledov:67
Število prenosov:16
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:International journal of molecular sciences
Skrajšan naslov:Int. j. mol. sci.
Založnik:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:celice CD34$^{+}$, periferna arterijska bolezen, kajenje, sladkorna bolezen, tip 2, prekinitvena klavdikacija

Projekti

Financer:University Medical Centre Ljubljana
Številka projekta:TP 20180022

Financer:University Medical Centre Ljubljana
Številka projekta:TP 20220018

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj